Dudediligence.

MeiraGTx Holdings plc

MGTXNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$10.9MSep ’24$21.4MDec ’24$1.9MMar ’25$3.7MJun ’25$410,000Sep ’25$75.4MDec ’25$293,000Mar ’26$321.4MJun ’26
Net income, by quarter
−$39.3MSep ’24−$39.4MDec ’24−$40.0MMar ’25−$38.8MJun ’25−$50.5MSep ’25$15.1MDec ’25−$46.3MMar ’26$160.7MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$37.7M$15.9M$14.0M$33.3M$81.4M
Operating income−$72.8M−$116.4M−$137.1M−$164.2M−$106.0M
Net income−$79.6M−$129.6M−$84.0M−$147.8M−$114.2M
Operating cash flow−$10.5M−$73.1M−$105.4M−$104.5M−$46.4M
Free cash flow−$56.9M−$118.1M−$125.5M−$109.5M−$50.2M
Cash$137.7M$115.5M$129.6M$103.7M$65.9M
Shares outstanding44.5M48.5M63.6M78.4M81.1M